Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025 GlobeNewswire October 17, 2025 Presentations to highlight JADE101's preclinical safety profile and translational framework guiding its clinical development in IgA nephropathy JADE101 is an investigational, potentially best-in-class disease-modifying anti-APRIL monoclonal antibody, with a Phase 1 healthy volunteer study […]

4DMT Announces New Employment Inducement Grants

4DMT Announces New Employment Inducement Grants GlobeNewswire October 17, 2025 EMERYVILLE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on October 14,

Northeast Recovery LLC Announces Acquisition of Collateral from Ark National Holdings LLC Pursuant to UCC 9-620

Northeast Recovery LLC (“Northeast Recovery”) today announced that it has completed a debt-for-assets transaction with Ark National Holdings LLC (“Ark Behavioral Health”), a leading provider of clinical, medical, and psychiatric care for substance use, mental health, and co-occurring disorders in Massachusetts. Pursuant to the transaction, consummated pursuant to Section 9-620 of the Uniform Commercial Code,

MountainWest Capital Network Recognizes Nectar as Fastest Growing Company on 2025 Utah 100 List

Utah 100 highlights healthcare, AI and construction sector growth as state's business landscape continues to thrive MountainWest Capital Network (MWCN) recognized Nectar as the top company on the 2025 Utah 100 during its 31st annual awards event. First presented in 1994, the Utah 100 is MWCN's yearly list of the fastest-growing companies in the Beehive

GIBO Holdings Limited Announces Transfer to Nasdaq Capital Market

GIBO Holdings Limited (“GIBO” or the “Company”), a unique and integrated AIGC animation streaming platform, today announced that the Company has received approval from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC to transfer the listing of the Company's Class A ordinary shares from the Nasdaq Global Market to the Nasdaq Capital

Stampli solidifies P2P leadership with multiple G2 Leader recognitions across procurement, AP, and payments

With Billy, the AI employee that operates procure-to-pay, Stampli earns finance teams' praise for intelligent automation, harmonious ERP integrations, and exceptional support. Stampli, the software to run any procure-to-pay (P2P) process – and Billy, the AI employee that operates it – today announced it has been recognized as a Leader across nine categories in G2's

FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients aged 12 years and older. TEZSPIRE

Rosen Law Firm Encourages Purchasers of Consensys Software, Inc. Tokens to Inquire About Securities Class Action Investigation

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of investors in liquid staking tokens (calledstETH and rETH) sold by Consensys Software, Inc., resulting from allegations that Consensys may have issued materially misleading business information to the investing public. So What: If you purchased stETH

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

(NASDAQ:CYTK), SOUTH SAN FRANCISCO, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 15, 2025 it granted stock options to purchase an aggregate of 109,120 shares of common stock and 73,535 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 83

Cynthia Gardens Announces Special Daily Discounts on Apartments in Boca Raton

Boca Raton, FL, Oct. 17, 2025 (GLOBE NEWSWIRE) — Cynthia Gardens, a renowned apartment community in Boca Raton, is thrilled to announce a new initiative offering special daily discounts on its modern one-bedroom apartments. This exciting opportunity is designed to provide prospective residents with an affordable entry into one of Boca Raton's most sought-after living

Scroll to Top